Inato

What is Inato?

Inato is an AI-powered clinical trial platform that connects sponsors, research sites and patients to speed enrollment and improve diversity. It combines study planning, site matching and patient pre-screening.

Key capabilities of Inato

• Early planning: Portfolio optimization for trial planning
• Site selection and matching: AI picks qualified, motivated sites by actual capabilities and patient access
• Automated chart review: Automates review of patient charts
• Patient pre-screening: Screens patients for eligibility
• Enrollment acceleration: Tools to speed recruitment
• eClinPro integration: Supports patient screening and enrollment

How Inato works

Sponsors use Inato to plan a trial and find the right mix of sites based on real capabilities and patient access. Once sites are active, AI automates chart review and pre-screening to surface eligible patients. The platform spans 6,000+ research sites across 50+ countries.

Who uses Inato?

Pharmaceutical sponsors and research sites. Inato says 25+ sponsors use it, with clients including Sanofi, Amgen, Pfizer, Eli Lilly and AstraZeneca. It won a Fierce AI Innovation Award in 2026 for clinical trial operations.

Inato pricing

Inato does not disclose pricing on its homepage. Users can sign in through its marketplace or request a demo.

Inato alternatives

Alternatives include Citeline for trial intelligence and site selection, TriNetX for real-world data based trial feasibility, and Antidote for patient matching.